Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron D Bowditch

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|March 22, 2005
ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activityLance C Bridges, Ron D Bowditch
The Biochemical Journal|October 27, 2004
ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7Lance C Bridges, Dean Sheppard, Ron D Bowditch
The Biochemical Journal|June 20, 2002
In vitro selection of fibronectin gain-of-function mutationsPatricia H Tani, Joseph C Loftus, Ron D Bowditch
Biochemistry|April 2, 2003
Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domainLance C Bridges, Krista R Hanson, Patricia H Tani, et al.
Anticancer Research|August 21, 2003
Matrix-dependent plasticity of the malignant phenotype of bladder cancer cellsRobert E Hurst, Kimberly D Kyker, Rebecca B Bonner, et al.
The Journal of Biological Chemistry|November 29, 2001
The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1Lance C Bridges, Patricia H Tani, Krista R Hanson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|March 22, 2005
ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activityLance C Bridges, Ron D Bowditch
The Biochemical Journal|October 27, 2004
ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7Lance C Bridges, Dean Sheppard, Ron D Bowditch
The Biochemical Journal|June 20, 2002
In vitro selection of fibronectin gain-of-function mutationsPatricia H Tani, Joseph C Loftus, Ron D Bowditch
Biochemistry|April 2, 2003
Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domainLance C Bridges, Krista R Hanson, Patricia H Tani, et al.
Anticancer Research|August 21, 2003
Matrix-dependent plasticity of the malignant phenotype of bladder cancer cellsRobert E Hurst, Kimberly D Kyker, Rebecca B Bonner, et al.
The Journal of Biological Chemistry|November 29, 2001
The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1Lance C Bridges, Patricia H Tani, Krista R Hanson, et al.
Pageof 1